论文部分内容阅读
目的:观察丝裂霉素(mitomycin C,MMC)联合Ahmed减压阀植入术治疗难治性青光眼的疗效。方法:应用Ahmed青光眼减压阀植入手术治疗32例35眼难治性青光眼,术后随访一年,观察其临床疗效及其手术并发症。结果:本组成功率为80.0%;眼压由术前的(47.28±13.14)mmHg降至术后的(17.62±6.42)mmHg。采用配对t检验差异有统计学意义(P<0.01)。术后并发症为:引流盘周纤维包裹2眼(5.7%),浅前房2眼(5.7%),引流管口堵塞2眼(5.7%),脉络膜脱离1眼(2.8%)。结论:应用丝裂霉素联合Ahmed减压阀植入手术治疗难治性青光眼是一种相对有效、安全的治疗方法。
Objective: To observe the effect of mitomycin C (MMC) combined with Ahmed valve implantation in the treatment of refractory glaucoma. Methods: Ahmed glaucoma valve implantation surgery in 32 patients with refractory glaucoma of 35 cases, followed up for one year after surgery to observe its clinical efficacy and surgical complications. Results: The success rate of this group was 80.0%. The intraocular pressure decreased from (47.28 ± 13.14) mmHg preoperatively to (17.62 ± 6.42) mmHg postoperatively. Paired t test showed significant difference (P <0.01). The postoperative complications were as follows: 2 eyes (5.7%) were perfused with periwound fibers, 2 eyes (5.7%) with shallow anterior chamber, 2 eyes (5.7%) with drainage orifice and 1 eye (2.8%) with choroidal detachment. Conclusion: Mitomycin combined with Ahmed valve implantation surgery for refractory glaucoma is a relatively effective and safe treatment.